1. Home
  2. SYRE vs ACLS Comparison

SYRE vs ACLS Comparison

Compare SYRE & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.30

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$93.41

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
ACLS
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
SYRE
ACLS
Price
$33.30
$93.41
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$56.50
$100.80
AVG Volume (30 Days)
795.0K
481.1K
Earning Date
02-26-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.25
Revenue
N/A
$853,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.90
P/E Ratio
N/A
$21.91
Revenue Growth
N/A
N/A
52 Week Low
$10.91
$40.40
52 Week High
$35.31
$102.93

Technical Indicators

Market Signals
Indicator
SYRE
ACLS
Relative Strength Index (RSI) 58.08 56.90
Support Level $30.00 $92.31
Resistance Level $34.21 $100.62
Average True Range (ATR) 1.83 3.99
MACD -0.02 0.74
Stochastic Oscillator 84.46 63.99

Price Performance

Historical Comparison
SYRE
ACLS

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

Share on Social Networks: